Facility Acquisition
Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
Fujifilm Biotechnologies
PR-M04-22-01Apr 04, 2022
Facility Acquisition
Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
Fujifilm Biotechnologies
PR-M01-22-18Jan 26, 2022
Strategic Alliance
FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process
FUJIFILM
PR-M01-22-05Jan 06, 2022
Partnership
Fujifilm Partners with Dr. Reddy's and Global Response Aid for Deployment of a COVID-19 Treatment Drug Outside of Japan
Nice Insight
PR-M06-20-NI-043Jul 02, 2020
Liposome Formulations
FUJIFILM Toyama Chemical Announces Completion of Japan’s First Manufacturing Facility for Commercial Liposome Formulations
FUJIFILM Toyama Chemical
PR-M12-19-NI-015Dec 10, 2019
Partnership
Fujifilm Expands RIS Revenue Cycle Solutions With Availity Partnership
FUJIFILM
PR-M06-18-NI-033Jun 12, 2018
Viral Vector
Flexible, Mobile, Modular: High-Containment Viral Vector Center of Excellence
Thomas Page, Ph.D.
Fujifilm Biotechnologies
PAP-Q2-18-CL-005May 29, 2018
Expansion
Fujifilm Announces The Expansion Of Its Fill Finish Services
Fujifilm Biotechnologies
PR-M05-18-NI-095May 25, 2018
Acquistion
FUJIFILM Expands into Bio-Medical Business with Acquisition
Marc Technow
Nice Insight
PR-M03-18-NI-103Mar 30, 2018
Imaging
Fujifilm Debuts ASPIRE Bellus II, A New Multimodality Mammography Workstation
FUJIFILM
PR-M03-18-NI-041Mar 12, 2018
Investment
FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.
Nice Insight
PAO-M11-17-NI-029Nov 17, 2017